Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors
Read MoreNewsroom
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round
Kestra Medical Technologies Surpasses 200 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System
Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference
Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award
ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study
Kestra Medical Technologies Receives FDA Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)